You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
希瑪眼科(03309.HK)預計年度由虧轉盈1500萬至2500萬港元
格隆匯 03-14 17:03

格隆匯3月14日丨希瑪眼科(03309.HK)發佈公吿,公司預計截至2021年12月31日止年度公司權益擁有人應占利潤將1500萬港元至2500萬港元,而截至2020年12月31日止年度則錄得虧損620萬港元。

集團於2021財政年度實現轉虧為盈,主要由於集團的收益由2020財政年度的6.995億港元大幅增加至2021財政年度的逾11億港元,增幅逾55%;與此同時,來自一家從事醫學實驗室服務的聯營公司的利潤貢獻份額增加,亦對集團2021財政年度的盈利作出正面貢獻。然而,收益增長對集團盈利的影響被集團處於投資初期的醫院及眼科中心造成的虧損所部分抵銷,其中包括惠州的新眼科醫院(於2021年3月開始營業)、珠海的眼科醫院(於2020年12月開始營業),以及福州的新眼科中心(於2021年11月開始營業)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account